v3.25.3
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Thousands
 9 Months Ended
Sep. 30, 2025
Sep. 30, 2024
Cash flows from operating activities:    
Net loss $ (73,553) $ (69,175)
Less: net income from discontinued operations, net of income taxes 0 (2,897)
Net loss from continuing operations (73,553) (72,072)
Adjustments to reconcile net loss from continuing operations to net cash used in operating activities from continuing operations:    
Depreciation and amortization 21,490 21,454
Stock-based compensation 5,096 5,691
Non-cash interest expense 3,811 4,373
Deferred income taxes (581) (4,968)
Provision for credit losses 1,325 673
Reduction in carrying amount of operating lease right-of-use assets 756 399
Change in fair value of earnout receivable 7,213 0
Changes in operating assets and liabilities:    
Accounts receivable (4,459) (1,289)
Prepaid expenses and other current assets (1,321) 1,965
Other assets (1,288) 77
Accounts payable (1,442) (7,397)
Deferred revenue 367 23
Accrued expenses and other current liabilities 1,565 2,465
Other non-current liabilities (142) 70
Net cash used in operating activities from continuing operations (41,163) (48,536)
Net cash provided by operating activities from discontinued operations 0 24,313
Net cash used in operating activities (41,163) (24,223)
Cash flows from investing activities:    
Capital expenditures (3,533) (4,932)
Sale of non-marketable equity investment 0 1,800
Net cash used in investing activities from continuing operations (3,533) (3,132)
Net cash used in investing activities from discontinued operations 0 (202)
Net cash used in investing activities (3,533) (3,334)
Cash flows from financing activities:    
Repayment of senior secured term loan (5,813) (3,875)
Proceeds from issuance of stock and pre-funded warrants under registered direct offerings and at-the-market offering, net of offering costs 70,896 0
Debt issuance costs (114) 0
Proceeds from issuance of stock under employee stock plans, net 299 433
Taxes paid related to net share settlement of equity awards (394) (653)
Settlement of deferred consideration for acquisitions 0 (1,800)
Net cash provided by (used in) financing activities from continuing operations 64,874 (5,895)
Net cash provided by financing activities from discontinued operations 0 0
Net cash provided by (used in) financing activities 64,874 (5,895)
Effect of exchange rates on cash, cash equivalents, and restricted cash (973) 0
Net change in cash, cash equivalents, and restricted cash 19,205 (33,452)
Cash, cash equivalents, and restricted cash, beginning of period 17,318 80,306
Cash, cash equivalents, and restricted cash, end of period 36,523 46,854
Less: cash, cash equivalents, and restricted cash included in discontinued operations 0 (34,496)
Cash, cash equivalents, and restricted cash included in continuing operations 36,523 12,358
Non-cash investing and financing activities:    
Stock-based compensation capitalized as part of internal-use software 152 299
Lease liabilities arising from right-of-use assets 1,840 0
Shares issued for debt issuance costs 873 0
Capital expenditures included in accounts payable $ 388 $ 0

Source

10-Q PDF XBRL Zip